Attached files
file | filename |
---|---|
8-K - FORM 8-K - WebMD Health Corp. | d531785d8k.htm |
EX-99.4 - EX-99.4 - WebMD Health Corp. | d531785dex994.htm |
EX-99.1 - EX-99.1 - WebMD Health Corp. | d531785dex991.htm |
EX-99.3 - EX-99.3 - WebMD Health Corp. | d531785dex993.htm |
Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenue |
$ | 112,762 | $ | 106,947 | ||||
Cost of operations |
46,943 | 53,471 | ||||||
Sales and marketing |
30,933 | 30,103 | ||||||
General and administrative |
23,534 | 29,022 | ||||||
Depreciation and amortization |
6,853 | 6,930 | ||||||
Interest income |
21 | 11 | ||||||
Interest expense |
5,832 | 5,836 | ||||||
Gain on investments |
| 8,074 | ||||||
Other expense |
| 1,200 | ||||||
|
|
|
|
|||||
Loss before income tax provision (benefit) |
(1,312 | ) | (11,530 | ) | ||||
Income tax provision (benefit) |
226 | (3,753 | ) | |||||
|
|
|
|
|||||
Net loss |
$ | (1,538 | ) | $ | (7,777 | ) | ||
|
|
|
|
|||||
Net loss per common share - Basic and Diluted |
$ | (0.03 | ) | $ | (0.14 | ) | ||
|
|
|
|
|||||
Weighted-average shares outstanding - Basic and Diluted |
49,007 | 55,769 | ||||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenue |
||||||||
Public portal advertising and sponsorship |
$ | 93,438 | $ | 87,776 | ||||
Private portal services |
19,324 | 19,171 | ||||||
|
|
|
|
|||||
$ | 112,762 | $ | 106,947 | |||||
|
|
|
|
|||||
Earnings before interest, taxes, non-cash and other items (Adjusted EBITDA) (a) |
$ | 21,289 | $ | 11,251 | ||||
Interest, taxes, non-cash and other items (b) |
||||||||
Interest income |
21 | 11 | ||||||
Interest expense |
(5,832 | ) | (5,836 | ) | ||||
Income tax (provision) benefit |
(226 | ) | 3,753 | |||||
Depreciation and amortization |
(6,853 | ) | (6,930 | ) | ||||
Non-cash stock-based compensation |
(9,937 | ) | (16,900 | ) | ||||
Gain on investments |
| 8,074 | ||||||
Other expense |
| (1,200 | ) | |||||
|
|
|
|
|||||
Net loss |
$ | (1,538 | ) | $ | (7,777 | ) | ||
|
|
|
|
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. |
(b) | Reconciliation of Adjusted EBITDA to net loss. |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
March 31, 2013 | December 31, 2012 | |||||||
(unaudited) | ||||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 999,221 | $ | 991,835 | ||||
Accounts receivable, net |
101,813 | 106,622 | ||||||
Prepaid expenses and other current assets |
14,999 | 13,882 | ||||||
Deferred tax assets |
10,339 | 10,328 | ||||||
|
|
|
|
|||||
Total current assets |
1,126,372 | 1,122,667 | ||||||
Property and equipment, net |
62,808 | 66,604 | ||||||
Goodwill |
202,104 | 202,104 | ||||||
Intangible assets, net |
15,538 | 16,105 | ||||||
Deferred tax assets |
55,436 | 56,039 | ||||||
Other assets |
25,260 | 27,106 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 1,487,518 | $ | 1,490,625 | ||||
|
|
|
|
|||||
Liabilities and Stockholders Equity |
||||||||
Accrued expenses |
$ | 49,107 | $ | 64,256 | ||||
Deferred revenue |
97,220 | 92,176 | ||||||
Liabilities of discontinued operations |
1,506 | 1,506 | ||||||
|
|
|
|
|||||
Total current liabilities |
147,833 | 157,938 | ||||||
2.25% convertible notes due 2016 |
400,000 | 400,000 | ||||||
2.50% convertible notes due 2018 |
400,000 | 400,000 | ||||||
Other long-term liabilities |
22,742 | 22,698 | ||||||
Stockholders equity |
516,943 | 509,989 | ||||||
|
|
|
|
|||||
Total Liabilities and Stockholders Equity |
$ | 1,487,518 | $ | 1,490,625 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | (1,538 | ) | $ | (7,777 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
6,853 | 6,930 | ||||||
Non-cash interest, net |
1,082 | 1,082 | ||||||
Non-cash stock-based compensation |
9,937 | 16,900 | ||||||
Deferred income taxes |
(99 | ) | (3,971 | ) | ||||
Gain on investments |
| (8,074 | ) | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
4,809 | 23,890 | ||||||
Prepaid expenses and other, net |
(193 | ) | (4,023 | ) | ||||
Accrued expenses and other long-term liabilities |
(14,850 | ) | (11,694 | ) | ||||
Deferred revenue |
5,044 | 2,266 | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
11,045 | 15,529 | ||||||
Cash flows from investing activities: |
||||||||
Proceeds received from ARS option |
| 9,269 | ||||||
Purchases of property and equipment |
(2,876 | ) | (3,377 | ) | ||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
(2,876 | ) | 5,892 | |||||
Cash flows from financing activities: |
||||||||
Proceeds from exercise of stock options |
672 | 754 | ||||||
Cash used for withholding taxes due on stock-based awards |
(174 | ) | (911 | ) | ||||
Purchases of treasury stock |
(1,281 | ) | (415 | ) | ||||
|
|
|
|
|||||
Net cash used in financing activities |
(783 | ) | (572 | ) | ||||
|
|
|
|
|||||
Net increase in cash and cash equivalents |
7,386 | 20,849 | ||||||
Cash and cash equivalents at beginning of period |
991,835 | 1,121,217 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 999,221 | $ | 1,142,066 | ||||
|
|
|
|